Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 33 (5), 328-43

Pharmacokinetic Changes During Pregnancy and Their Clinical Relevance


Pharmacokinetic Changes During Pregnancy and Their Clinical Relevance

R Loebstein et al. Clin Pharmacokinet.


The dynamic physiological changes that occur in the maternal-placental-fetal unit during pregnancy influence the pharmacokinetic processes of drug absorption, distribution and elimination. Pregnancy-induced maternal physiological changes may affect gastrointestinal function and hence drug absorption rates. Ventilatory changes may influence the pulmonary absorption of inhaled drugs. As the glomerular filtration rate usually increases during pregnancy, renal drug elimination is generally enhanced, whereas hepatic drug metabolism may increase, decrease or remain unchanged. A mean increase of 8 L in total body water alters drug distribution and results in decreased peak serum concentrations of many drugs. Decreased steady-state concentrations have been documented for many agents as a result of their increased clearance. Pregnancy-related hypoalbuminaemia, leading to decreased protein binding, results in increased free drug fraction. However, as more free drug is available for either hepatic biotransformation or renal excretion, the overall effect is an unaltered free drug concentration. Since the free drug concentration is responsible for drug effects, the above mentioned changes are probably of no clinical relevance. The placental and fetal capacity to metabolise drugs together with physiological factors, such as differences acid-base equilibrium of the mother versus the fetus, determine the fetal exposure to the drugs taken by the mother. As most drugs are excreted into the milk by passive diffusion, the drug concentration in milk is directly proportional to the corresponding concentration in maternal plasma. The milk to plasma (M:P) ratio, which compares milk with maternal plasma drug concentrations, serves as an index of the extent of drug excretion in the milk. For most drugs the amount ingested by the infant rarely attains therapeutic levels.

Similar articles

  • The Pharmacokinetics of Antiarrhythmic Agents in Pregnancy and Lactation
    GM Mitani et al. Clin Pharmacokinet 12 (4), 253-91. PMID 3297463. - Review
    The pharmacokinetics of various drugs may be profoundly altered during different stages of pregnancy, parturition, and lactation. Gastrointestinal absorption or bioavaila …
  • Drugs in Human Milk. Clinical Pharmacokinetic Considerations
    HC Atkinson et al. Clin Pharmacokinet 14 (4), 217-40. PMID 3292101. - Review
    Drugs ingested by a lactating mother would be expected to appear in human milk to some extent and be ingested by a breast-feeding infant. Drugs pass from maternal plasma …
  • Using Pharmacokinetics to Predict the Effects of Pregnancy and Maternal-Infant Transfer of Drugs During Lactation
    GD Anderson. Expert Opin Drug Metab Toxicol 2 (6), 947-60. PMID 17125410. - Review
    Knowledge of pharmacokinetics and the use of a mechanistic-based approach can improve our ability to predict the effects of pregnancy for medications when data are limite …
  • Drug Kinetics in Pregnancy
    B Krauer et al. Clin Pharmacokinet 2 (3), 167-81. PMID 328205. - Review
    Any drug given to a pregnant woman must be considered as possibly harmful in the fetus, since all drugs administered to the mother cross the placental membrane, although …
  • Drug Disposition and Effects in the Fetus
    DW Rurak et al. J Dev Physiol 15 (1), 33-44. PMID 1678754. - Review
    Surveys of drug use in pregnancy demonstrate that a significant proportion of human fetuses are exposed to prescription and non-prescription drugs antenatally or during l …
See all similar articles

Cited by 68 PubMed Central articles

See all "Cited by" articles


    1. Obstet Gynecol. 1985 Dec;66(6):822-4 - PubMed
    1. Am Rev Tuberc. 1953 May;67(5):568-97 - PubMed
    1. Drug Metab Rev. 1983;14(4):619-52 - PubMed
    1. Drug Metab Dispos. 1993 Mar-Apr;21(2):364-8 - PubMed
    1. Lancet. 1971 May 1;1(7705):912 - PubMed